Browsing Tag
pharmaceutical licensing
2 posts
Sanofi invests up to $1bn in South Korean biotech ADEL to advance tau-based Alzheimer’s therapy
Sanofi has signed an up to $1 billion Alzheimer’s drug deal with South Korean biotech ADEL. Find out what the tau targeting strategy means for investors and patients.
Merck secures exclusive global license for opevesostat from Orion Corporation
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has enhanced its strategic position…